Halogenated Nucleosides
6-Chloro-9-[3,5-di-O-(p-toluoyl)-2-deoxy-beta-D-ribofuranosyl]-9H-purine
Quick view. We supply 6-Chloro-9-[3,5-di-O-(p-toluoyl)-2-deoxy-beta-D-ribofuranosyl]-9H-purine as a halogenated nucleoside analog for modified nucleoside, antiviral/antimetabolite and oligonucleotide precursor research. CAS 91713-46-1. Catalog target purity: Specification on request.
![Chemical structure of 6-Chloro-9-[3,5-di-O-(p-toluoyl)-2-deoxy-beta-D-ribofuranosyl]-9H-purine](/structures/ac1a6c074e9cda80.svg)
Product profile
6-Chloro-9-[3,5-di-O-(p-toluoyl)-2-deoxy-beta-D-ribofuranosyl]-9H-purine is classified as nucleoside or protected nucleoside intermediate (Formula C26H23ClN4O5; molecular weight 506.94).
6-Chloro-9-[3,5-di-O-(p-toluoyl)-2-deoxy-beta-D-ribofuranosyl]-9H-purine — A protected purine deoxynucleoside DNA adduct.
For 6-Chloro-9-[3,5-di-O-(p-toluoyl)-2-deoxy-beta-D-ribofuranosyl]-9H-purine, reported solubility: Chloroform, Dichloromethane, Ethyl Acetate. Form: Foam.
Names and search terms
Confirmed or normalized name variants
- 6-Chloro-9-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)pentofuranosyl]-9H-purine
- 3,5-O-Ditoluoyl 6-Chloropurine-9-β-D-deoxyriboside
- 6-Chloro-9-(2'-deoxy-3',5'-di-O-toluoyl-β-ribofuranosyl)purine
- 6-Chloro-9-(2'-deoxy-3',5'-di-O-toluoyl-b-ribofuranosyl)purine
- 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine
- 6-CHLORO-9-(3,5-O-DI(P-TOLUOYL)-BETA-D-2-DEOXYRIBOFURANOSYL) PURINE
- 6-Chloro-9-[3,5-di-O-(p-toluoyl)-2-deoxy-β-D-ribofuranosyl]-9H-purine
- 6-Chloro-9-[2-deoxy-3,5-bis-O-(4-Methylbenzoyl)-β-D-erythro-pentofuranosyl]purine
Useful catalog search terms
- CAS 91713-46-1
- Nucleoside or protected nucleoside intermediate
- Halogenated Nucleosides
Physicochemical data
| InChI | InChI=1S/C26H23ClN4O5/c1-15-3-7-17(8-4-15)25(32)34-12-20-19(36-26(33)18-9-5-16(2)6-10-18)11-21(35-20)31-14-30-22-23(27)28-13-29-24(22)31/h3-10,13-14,19-21H,11-12H2,1-2H3 |
|---|---|
| InChIKey | NSOAHTMBUMXVAF-UHFFFAOYSA-N |
| SMILES | Cc1ccc(C(=O)OCC2OC(n3cnc4c(Cl)ncnc43)CC2OC(=O)c2ccc(C)cc2)cc |
| Melting point | 111-113 °C(Solv: ethanol (64-17-5)) |
| Boiling point | 684.5±65.0 °C(Predicted) |
| Density | 1.42±0.1 g/cm3(Predicted) |
| pKa | 0.76±0.10(Predicted) |
| Form | Foam |
| Color | Off-White |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- 6-Chloro-9-[3,5-di-O-(p-toluoyl)-2-deoxy-beta-D-ribofuranosyl]-9H-purine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Related products
2'-5-CF3-dU
Halogenated Nucleosides · CAS: 70-00-8
BX-HN-00026-Cl-purine-2'-deoxyriboside
Halogenated Nucleosides · CAS: 4594-45-0
BX-HN-00038-Cl-2'-dA
Halogenated Nucleosides · CAS: 85562-55-6
BX-HN-00042'-Chloro-2'-deoxycytidine
Halogenated Nucleosides · CAS: 10212-19-8
BX-HN-00055-bromo-2'-deoxycytidine
Halogenated Nucleosides · CAS: 1022-79-3
BX-HN-00065-Iodouridine
Halogenated Nucleosides · CAS: 1024-99-3
Frequently asked questions
Can the package size for 6-Chloro-9-[3,5-di-O-(p-toluoyl)-2-deoxy-beta-D-ribofuranosyl]-9H-purine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-HN-0144 and CAS 91713-46-1, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Halogenated Nucleosides product family and its named chemistry.